Tag: disability

Chronic Conditions Surge in U.S. Workforce While Disability Claims Decline, Signaling a New Workforce Health Paradox

OAKLAND, Calif., June 26, 2025 /PRNewswire/ -- More than 78% percent of employees in the US now have at least one chronic condition, an...

Access Ready Strategic Joins Families USA and the CCD Rights Task Force Along with Other Organizations on Vital Policy and Public Interest Positions

Many Groups and Organizations respond on Policy Issues WASHINGTON, June 26, 2025 /PRNewswire/ -- The recent rapid approach to policy changes at the Federal and...

First Call Mechanical Joins UTI’s Student Early Employment Program

New collaboration provides real-world experience, $10,000 tuition reimbursement, and career advancement support for HVACR students. PHOENIX, June 25, 2025 /PRNewswire/ -- Universal Technical Institute (UTI), the...

From Wheelchair to Workhorse: Rapper with MS Builds a Brand, Drops Memoir That’s Moving More Than Music

Robert "B-Cide" Cardillo II's book "Myelin My Shoes" is now available, blending memoir, music, and merch into one powerful package. UTICA, N.Y., June 23, 2025...

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

– Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 23, 2025 /PRNewswire/ -- PTC Therapeutics, Inc....

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at...

Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition

Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., developer of the Life Backup Plan digital health platform, proudly announces its advancement to the second round of Pepperdine University’s Most Fundable Companies® 2025 competition. The company earned a “B” rating, reflecting “Great Potential” among a competitive national pool of startups evaluated for scalability, business fundamentals, and investor appeal.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsDisability

Myanmar Construction Industry Report 2025 | Output to Register an AAGR of 3.9% During 2026-2029, Supported by Investments in Renewable Energy, Infrastructure Projects, and...

Middlefield Canadian Income PCC – Dividend Declaration

HUTCHMED to Announce 2025 Half-Year Financial Results

Tag: disability

Chronic Conditions Surge in U.S. Workforce While Disability Claims Decline, Signaling a New Workforce Health Paradox

Access Ready Strategic Joins Families USA and the CCD Rights Task Force Along with Other Organizations on Vital Policy and Public Interest Positions

First Call Mechanical Joins UTI’s Student Early Employment Program

From Wheelchair to Workhorse: Rapper with MS Builds a Brand, Drops Memoir That’s Moving More Than Music

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

BIC: Remuneration of Corporate Officer

Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia

Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us